Picture of Mycelx Technologies logo

MYX Mycelx Technologies News Story

0.000.00%
gb flag iconLast trade - 00:00
IndustrialsHighly SpeculativeMicro CapNeutral

REG - MyCelx Tech. Corp. MyCelx Tech. Cp-MYXR - Director Dealing

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240326:nRSZ3857Ia&default-theme=true

RNS Number : 3857I  MyCelx Technologies Corporation  26 March 2024

26 March 2024

 

MYCELX Technologies Corporation

("MYCELX" or the "Company" (AIM: MYX)

 

 

Director Dealing

 

The Company announces that it was notified by Tom Lamb, Chairman of the Board
of Directors of the Company, that on 26 March 2024, he purchased 12,000 common
shares in the Company of US$0.025 each ("Common Shares"), at a price of £0.50
per Common Share. Following this transaction, Mr. Lamb holds 325,175 Common
Shares representing 1.41 per cent of the total issued capital of the Company.

 

 

For further information please contact:

 

 MYCELX Technologies Corporation

 Connie Mixon, CEO                     Tel: +1 888 306 6843

 Kim Slayton, CFO

 Canaccord Genuity, Nominated Adviser

 Henry Fitzgerald-O'Connor             Tel: + 44 20 7523 8000

 Ana Ercegovic

 Celicourt

 Mark Antelme                          Tel: +44 20 7770 6424

 Jimmy Lea

 Charlie Denley-Myerson

 

Notification of transactions of persons discharging managerial responsibility
or connected persons

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Tom Lamb

 2    Reason for the notification

 a)   Position/status                                              Non-Executive Chairman

 b)   Initial notification /Amendment                              Initial notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         MYCELX Technologies Corporation

 b)   LEI                                                          213800UJZINIK2VD1G48

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument

                                                                   Common shares of US$0.025

                                                                   ISIN: US62847T2024

 b)   Nature of the transaction                                    Purchase of Common Shares in GBP

 c)   Price(s) and volume(s)

Price(s)  Volume(s)

                                                                   £0.50     12,000

 

 d)   Aggregated information

      - Aggregated volume                                          n/a

      - Price                                                      n/a

 e)   Date of the transaction                                      26/03/2024

 f)   Place of the transaction                                     London Stock Exchange (AIM)

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

n/a

 

 

n/a

 

 

e)

 

Date of the transaction

 

 

26/03/2024

f)

 

Place of the transaction

 

 

London Stock Exchange (AIM)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  STREQLFLZXLFBBB

Recent news on Mycelx Technologies

See all news